Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Vertex Pharmaceuticals Incorporated (Vertex or 'the company') is a biotechnology company engaged in the discovery, development and commercialization of new medicines. The company primarily operates in the US, Canada and Europe. It is headquartered in Boston, Massachusetts, and employed approximately 1,830 people as on December 31, 2014.

Scope

– Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis

– An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments

– Intelligence on Vertex Pharmaceuticals Incorporated's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Vertex Pharmaceuticals Incorporated's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Vertex Pharmaceuticals Incorporated: Company Overview

Vertex Pharmaceuticals Incorporated: Overview and Key Facts

Vertex Pharmaceuticals Incorporated: Overview

Vertex Pharmaceuticals Incorporated: Key Facts

Vertex Pharmaceuticals Incorporated: Key Employees

Vertex Pharmaceuticals Incorporated: Key Employee Biographies

Vertex Pharmaceuticals Incorporated: Major Products and Services

Vertex Pharmaceuticals Incorporated: Company History

Vertex Pharmaceuticals Incorporated: Management Statement

Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries

Vertex Pharmaceuticals Incorporated: Key Competitors

Vertex Pharmaceuticals Incorporated: Company Analysis

Vertex Pharmaceuticals Incorporated: Business Description

Vertex Pharmaceuticals Incorporated: SWOT Analysis

Vertex Pharmaceuticals Incorporated: SWOT Overview

Vertex Pharmaceuticals Incorporated: Strengths

Vertex Pharmaceuticals Incorporated: Weaknesses

Vertex Pharmaceuticals Incorporated: Opportunities

Vertex Pharmaceuticals Incorporated: Threats

Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity

Vertex Pharmaceuticals Incorporated: Financial Deals Overview

Vertex Pharmaceuticals Incorporated: Targets and Partners

Vertex Pharmaceuticals Incorporated: Top Deals 2013 - 2017YTD*

Vertex Pharmaceuticals Incorporated: Corporate Venturing

Vertex Pharmaceuticals Incorporated: Partnership

Vertex Pharmaceuticals Incorporated: Recent Developments

Vertex Pharmaceuticals Incorporated: News and Events Summary

Vertex Pharmaceuticals Incorporated: Contracts

Vertex Pharmaceuticals Incorporated: Corporate Governance

Vertex Pharmaceuticals Incorporated: Financial Performance

Vertex Pharmaceuticals Incorporated: Grants

Vertex Pharmaceuticals Incorporated: Research & Development

Vertex Pharmaceuticals Incorporated: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About MarketLine

List of Tables

List of Tables

Table 1: Vertex Pharmaceuticals Incorporated: Key Facts

Table 2: Vertex Pharmaceuticals Incorporated: Key Employees

Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries

Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors

Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type – Volume (TTM*)

Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Table 7: Vertex Pharmaceuticals Incorporated: Targets and Partners

Table 8: Vertex Pharmaceuticals Incorporated: Top Deals 2013 – 2017YTD*

Table 9: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2013 – YTD*2017)

Table 10: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2013 – YTD*2017)

Table 11: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2013 – YTD*2017)

Table 12: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2013 – YTD*2017)

Table 13: Vertex Pharmaceuticals Incorporated: News and Events Summary

Table 14: Vertex Pharmaceuticals Incorporated: Contracts

Table 15: Vertex Pharmaceuticals Incorporated: Corporate Governance

Table 16: Vertex Pharmaceuticals Incorporated: Financial Performance

Table 17: Vertex Pharmaceuticals Incorporated: Grants

Table 18: Vertex Pharmaceuticals Incorporated: Research & Development

Table 19: Vertex Pharmaceuticals Incorporated: Strategy and Operations

List of Figures

List of Figures

Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Figure 3: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2013 – YTD*2017)

Figure 4: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2013 – YTD*2017)

Figure 5: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2013 – YTD*2017)

Figure 6: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2013 – YTD*2017)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports